• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DICE Therapeutics, Inc. - Common Stock (NQ:DICE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 47.45 (10)
Ask (Size) 47.81 (2)
Prev. Close 47.55
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 47,790,092
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs
September 01, 2023
Via Investor Brand Network
News headline image
Why These 3 Large Caps Are Bucking the August Slump
August 22, 2023
The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023. 
Via MarketBeat
Topics Economy Stocks

Performance

More News

Read More
News headline image
What 9 Analyst Ratings Have To Say About DICE Therapeutics ↗
August 09, 2023
Via Benzinga
News headline image
Analyst Expectations for DICE Therapeutics's Future ↗
June 20, 2023
Via Benzinga
News headline image
Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics ↗
June 20, 2023
Via Benzinga
News headline image
Top 5 Health Care Stocks That May Crash In Q3 ↗
August 07, 2023
Via Benzinga
News headline image
Eli Lilly To Report Q2 Earnings: What's In The Cards? ↗
August 05, 2023
Via Talk Markets
M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)
July 26, 2023
Via Investor Brand Network
Topics Intellectual Property
News headline image
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022 ↗
July 17, 2023
Via Benzinga
News headline image
DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE
July 10, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why Shares of Ventyx Biosciences Rose Monday ↗
July 03, 2023
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023 ↗
June 26, 2023
Via Benzinga
News headline image
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review ↗
June 23, 2023
Via Investor's Business Daily
News headline image
Why Dice Therapeutics Stock Bolted Higher This Week ↗
June 22, 2023
Via The Motley Fool
News headline image
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event? ↗
June 21, 2023
Via The Motley Fool
News headline image
DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE
June 21, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023 ↗
June 21, 2023
Via Benzinga
News headline image
Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover
June 21, 2023
Via MarketBeat
News headline image
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know ↗
June 20, 2023
Via The Motley Fool
News headline image
Crude Oil Down 2%; Dragonfly Energy Shares Plunge ↗
June 20, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
June 20, 2023
Via Benzinga
News headline image
Dow Dips Over 300 Points; DICE Therapeutics Shares Spike Higher ↗
June 20, 2023
Via Benzinga
News headline image
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
June 20, 2023
Via Benzinga
Eli Lilly (NYSE: LLY) Acquires DICE Therapeutics (NASDAQ: DICE): A New Step in Autoimmune Disease Treatments
June 20, 2023
Via Spotlight Growth
News headline image
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday ↗
June 20, 2023
Via The Motley Fool

Frequently Asked Questions

Is DICE Therapeutics, Inc. - Common Stock publicly traded?
Yes, DICE Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does DICE Therapeutics, Inc. - Common Stock trade on?
DICE Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DICE Therapeutics, Inc. - Common Stock?
The ticker symbol for DICE Therapeutics, Inc. - Common Stock is DICE on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap